Abstract:BACKGROUND: Endomorphin-1 and endo morphin-2 are endogenous peptides that are highly selective for A-opioid receptors. However, studies of their functional efficacy and selectivity are controversial. In this study, we systematically compared the effects of intrathecal (i.t.) administration of endomorphin-1 and -2 on nociception assays and G protein activation with those of [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephatin (DANIGO), a highly effective peptidic A-opioid receptor agonist. METHODS: Mate Sprague-Dawley rats were used. Acute and inflammatory pain models were used to compare the duration and magnitude of antinociception. Agonist-stimulated [S-35]GTP-gamma S binding was used to observe the functional activity at the level of the receptor-G protein in both spinal cord and thalamic membranes. In addition, antagonists selective for each receptor type were used to verify the functional selectivity of endomorphins in the rat spinal cord. RESULTS: After i.t. administration, endomorphin-1 and -2 produced less antinociceptive effects than DAMGO in the model of acute pain. Concentration-response curves for DAMGO-, enclomorphin-1-,and endomorphin-2-stimulated [S-35]GTP-gamma S binding revealed that both endomorphin-1 and -2 produced less G protein activation (i.e., approximately 50%-60%) than DAMGO did in the membranes of spinal cord and thalamus. In addition, i.t. endomorphin-induced antinociception was blocked by mu-opioid receptor selective dose of naltrexone (P < 0.05), but not by delta- and kappa-Opioid receptor antagonists, naltrindole and nor-binaltorphimine (P > 0.05). CONCLUSIONS: Endomorphins are partial agonists for G protein activation at spinal and thalamic mu-opioid receptors. Both in vivo and in vitro measurements together suggest that DAMGO is more effective than enclomorphins. Spinal endomorphins' antinociceptive efficacy may range between 53% and 84% depending on the intensity and modality of the nociceptive stimulus.

The Antinociceptive Effects and Molecular Mechanisms of Ghrelin(1–7)-Nh2 at the Supraspinal Level in Acute Pain in Mice

Study on the Molecular Mechanism of Antinociception Induced by Ghrelin in Acute Pain in Mice

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

In vivo characterization of the effects of ghrelin on the modulation of acute pain at the supraspinal level in mice.

The Active Fragments of Ghrelin Cross the Blood-Brain Barrier and Enter the Brain to Produce Antinociceptive Effects after Systemic Administration

Antinociceptive Effects Of Analgesic-Antitumor Peptide (Agap), A Neurotoxin From The Scorpion Buthus Martensii Karsch, On Formalin-Induced Inflammatory Pain Through A Mitogen-Activated Protein Kinases-Dependent Mechanism In Mice

Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice.

Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice.

Effects of Nociceptin (13–17) in Pain Modulation at Supraspinal Level in Mice

Effects and Mechanisms of Supraspinal Administration of Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide, on Nociception in Mice

Analgesic Activities of the Mixed Opioid and NPFF Receptors Agonist DN-9 in a Mouse Model of Formalin-Induced Orofacial Inflammatory Pain.

The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies

Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] γ2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice

Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain Hypersensitivity

Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking

Synergistic Interaction Between DAMGO-NH2 and NOP01 in Peripherally Acting Antinociception in Two Mouse Models of Formalin Pain

Novel chimeric peptides based on endomorphins and ghrelin receptor antagonist produced supraspinal antinociceptive effects with reduced acute tolerance in mice

Pain Regulation of Endokinin A/B or Endokinin C/D on Chimeric Peptide MCRT in Mice.

MrgC Agonism at Central Terminals of Primary Sensory Neurons Inhibits Neuropathic Pain

Annexin 1 Exerts Anti-Nociceptive Effects after Peripheral Inflammatory Pain Through Formyl-Peptide-receptor-like 1 in Rat Dorsal Root Ganglion